Your browser doesn't support javascript.
Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies.
Nishikubo, Masashi; Shimomura, Yoshimitsu; Yamamoto, Ryusuke; Yoshioka, Satoshi; Maruoka, Hayato; Nasu, Seiko; Nishioka, Tomomi; Sakizono, Kenji; Mitsuyuki, Satoshi; Kubo, Tomoyo; Okada, Naoki; Nakagawa, Daishi; Kamijo, Kimimori; Imoto, Hiroharu; Nagai, Yuya; Hiramoto, Nobuhiro; Yonetani, Noboru; Kondo, Tadakazu; Miyakoshi, Chisato; Doi, Asako; Ishikawa, Takayuki.
  • Nishikubo M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Shimomura Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan. shimomura_0119@yahoo.co.jp.
  • Yamamoto R; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan. shimomura_0119@yahoo.co.jp.
  • Yoshioka S; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Maruoka H; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Nasu S; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Nishioka T; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Sakizono K; LSI Medience Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Mitsuyuki S; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Kubo T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Okada N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Nakagawa D; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Kamijo K; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Imoto H; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Nagai Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Yonetani N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Kondo T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Miyakoshi C; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Doi A; Department of Research Support, Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
  • Ishikawa T; Department of Infectious diseases, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Blood Cancer J ; 13(1): 17, 2023 Jan 23.
Article in English | MEDLINE | ID: covidwho-2211941
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Cancer J Year: 2023 Document Type: Article Affiliation country: S41408-023-00792-z

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Cancer J Year: 2023 Document Type: Article Affiliation country: S41408-023-00792-z